A small tweak to an email encouraging federal employees to take a buyout indicates the Justice Department wouldn’t vouch for ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...